Cite
HARVARD Citation
D'Urzo, A. et al. (n.d.). P252 Once-daily NVA237 improves symptoms, and reduces COPD exacerbations and associated hospitalisations: the GLOW1 trial. Thorax. p. A170. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
D'Urzo, A. et al. (n.d.). P252 Once-daily NVA237 improves symptoms, and reduces COPD exacerbations and associated hospitalisations: the GLOW1 trial. Thorax. p. A170. [Online].